AMCo allocates, merges, makes hefty scalebacks
Amdipharm Mercury, the UK generic pharmaceuticals company also known as AMCo, has allocated a €603.2m loan that raises new money and reprices existing facilities.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: